#xbb_1_9 — Public Fediverse posts

Here's the latest variant picture for New Zealand.

EG.5.* "Eris" (53%) was still dominant, as of late October, but was beginning to wane.

XBB.1.9.* "Hyperion" began rising during October.

BA.2.86.* "Pirola" (2%) was not significant.

#COVID19 #NZ #EG_5 #Eris #XBB_1_9 #Hyperion #BA_2_86 #Pirola
🧵

Here's the latest variant picture for New Zealand.

XBB.1.5.* "Kraken" (28%) has rebounded to overtake CH.1.1.* "Orthrus" (25%). XBB.1.16.* "Arcturus" (16%) and XBB.1.9.* "Hyperion" (19%) are still significant.

The new EG.5.* variant (5%) is present and growing, but is not significant yet.

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to July 10.

#COVID19 #NZ #XBB_1_5 #Kraken #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

XBB.1.5.* "Kraken" (28%) has rebounded to overtake CH.1.1.* "Orthrus" (25%). XBB.1.16.* "Arcturus" (16%) and XBB.1.9.* "Hyperion" (19%) are still significant.

The new EG.5.* variant (5%) is present and growing, but is not significant yet.

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to July 10.

#COVID19 #NZ #XBB_1_5 #Kraken #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

XBB.1.5.* "Kraken" (28%) has rebounded to overtake CH.1.1.* "Orthrus" (25%). XBB.1.16.* "Arcturus" (16%) and XBB.1.9.* "Hyperion" (19%) are still significant.

The new EG.5.* variant (5%) is present and growing, but is not significant yet.

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to July 10.

#COVID19 #NZ #XBB_1_5 #Kraken #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

XBB.1.5.* "Kraken" (28%) has rebounded to overtake CH.1.1.* "Orthrus" (25%). XBB.1.16.* "Arcturus" (16%) and XBB.1.9.* "Hyperion" (19%) are still significant.

The new EG.5.* variant (5%) is present and growing, but is not significant yet.

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to July 10.

#COVID19 #NZ #XBB_1_5 #Kraken #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

XBB.1.5.* "Kraken" (28%) has rebounded to overtake CH.1.1.* "Orthrus" (25%). XBB.1.16.* "Arcturus" (16%) and XBB.1.9.* "Hyperion" (19%) are still significant.

The new EG.5.* variant (5%) is present and growing, but is not significant yet.

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to July 10.

#COVID19 #NZ #XBB_1_5 #Kraken #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for Western Australia.

"Deltacron" XBC.* (31%) and XBB.1.16.* "Arcturus" (31%) are the leading variants in a messy soup.

Among the individual lineages, there was recent growth in XBB.1.9.1 (12%) - a "Hyperion" sub-lineage.

The XBC.1.3 sub-lineage (14%) is the most common from that variant, vs XBC.1.6.* in South Australia.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to July 6.

#COVID19 #Australia #QLD #Brisbane #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBC #Deltacron @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Queensland, Australia.

XBB.1.16.* "Arcturus" (30%), XBB.1.9.* "Hyperion" (24%) and "Deltacron" XBC.* (22%) are the leading variants in a messy soup.

Among the individual lineages, there was recent growth in EG.1 (9%) - a "Hyperion" sub-lineage.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to July 2.

#COVID19 #Australia #QLD #Brisbane #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBC #Deltacron @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for New South Wales, Australia.

XBB.1.9.* "Hyperion" (29%) and XBB.1.16.* "Arcturus" (28%) are the leading variants in a messy soup.

Among the individual lineages, there was recent growth in XBB.1.16.2 (11%).

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to July 4.

#COVID19 #Australia #NSW #Sydney #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for New Zealand.

CH.1.1.* "Orthrus" (36%) rebounded to a leading position, in a close contest with XBB.1.16.* "Arcturus" (29%) and XBB.1.9.* "Hyperion" (29%).

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to June 22. Unfortunately, the update cycle for NZ seems to have fallen back to once a month. Any successful new variant will likely already be widespread by the time it appears in this data. More timely summarised frequencies are shared weekly (not via GISAID), but for a very limited set of variants.

#COVID19 #NZ #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

CH.1.1.* "Orthrus" (36%) rebounded to a leading position, in a close contest with XBB.1.16.* "Arcturus" (29%) and XBB.1.9.* "Hyperion" (29%).

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to June 22. Unfortunately, the update cycle for NZ seems to have fallen back to once a month. Any successful new variant will likely already be widespread by the time it appears in this data. More timely summarised frequencies are shared weekly (not via GISAID), but for a very limited set of variants.

#COVID19 #NZ #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

CH.1.1.* "Orthrus" (36%) rebounded to a leading position, in a close contest with XBB.1.16.* "Arcturus" (29%) and XBB.1.9.* "Hyperion" (29%).

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to June 22. Unfortunately, the update cycle for NZ seems to have fallen back to once a month. Any successful new variant will likely already be widespread by the time it appears in this data. More timely summarised frequencies are shared weekly (not via GISAID), but for a very limited set of variants.

#COVID19 #NZ #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

CH.1.1.* "Orthrus" (36%) rebounded to a leading position, in a close contest with XBB.1.16.* "Arcturus" (29%) and XBB.1.9.* "Hyperion" (29%).

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to June 22. Unfortunately, the update cycle for NZ seems to have fallen back to once a month. Any successful new variant will likely already be widespread by the time it appears in this data. More timely summarised frequencies are shared weekly (not via GISAID), but for a very limited set of variants.

#COVID19 #NZ #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for New Zealand.

CH.1.1.* "Orthrus" (36%) rebounded to a leading position, in a close contest with XBB.1.16.* "Arcturus" (29%) and XBB.1.9.* "Hyperion" (29%).

The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.

The sample volumes seem representative up to June 22. Unfortunately, the update cycle for NZ seems to have fallen back to once a month. Any successful new variant will likely already be widespread by the time it appears in this data. More timely summarised frequencies are shared weekly (not via GISAID), but for a very limited set of variants.

#COVID19 #NZ #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵

Here's the latest variant picture for Victoria.

XBB.1.16.* "Arcturus" (34%) is taking it's turn to dominate, following XBB.1.9.* "Hyperion" (24%).

XBB.1.5.* "Kraken" (13%) has been declining steadily.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

#COVID19 #Australia #VIC #Melbourne #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken @auscovid19
🧵

Here's the latest variant picture for China.

XBB.1.9.* "Hyperion" (39%) was driving the 2nd wave of recombinant lineages, with perhaps some slow growth for XBB.1.16.* "Arcturus" (24%).

There was a fairly dramatic surge in XBB.1.22.* "Bellatrix" (60%) in early June. Note that the samples from June 6 onwards are almost all from Hubei province (Wuhan region).

This looks like a clear signal of a fresh wave of reinfections. I couldn't find any current info on the situation in Hubei.

The sample volumes seem representative up to June 1, perhaps a week later for Hubei province.

#COVID19 #China #Hubei #XBB_1_9 #Hyperion #XBB_1_22 #Bellatrix
🧵

Here's the latest variant picture for the United Kingdom.

XBB.1.9.* "Hyperion" (39%) is driving the current wave, taking over from XBB.1.5 "Kraken" (26%).

XBB.1.16.* "Arcturus" (21%) is also rising.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

#COVID19 #UK #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus
🧵

Here's the latest variant picture for Western Australia.

XBB.1.9.* "Hyperion" (40%) and XBB.1.16.* "Arcturus" (31%), appear to be battling for dominance

The sample volumes seem representative up to June 1.

#COVID19 #Australia #WA #Perth #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Queensland, Australia.

It's difficult to interpret as sample volumes are very low and patchy. There's a lengthy gap where <10 samples were shared, between May 13 and May 24.

XBB.1.9.* "Hyperion" (24%) may have returned to dominance. It looks like the many sub-lineages including EG.* and FL.* are making a contribution

#COVID19 #QLD #Brisbane #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for New South Wales, Australia.

XBB.1.16.* "Arcturus" (32%) is taking it's turn to dominate, following XBB.1.9.* "Hyperion" (25%).

XBB.1.5.* "Kraken" (14%) has been declining steadily.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to June 5.

#COVID19 #Australia #NSW #Sydney #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Victoria.

XBB.1.16.* "Arcturus" (34%) is taking it's turn to dominate, following XBB.1.9.* "Hyperion" (24%).

XBB.1.5.* "Kraken" (12%) has been declining steadily.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to June 5.

#COVID19 #Australia #VIC #Melbourne #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Western Australia.

The XBC.* Deltacron variant clan (31%) appears to have surged to dominance, although recent samples are a bit patchy.

You could throw a blanket over XBB.1.16.* "Arcturus" (20%), XBB.1.9.* "Hyperion" (19%) and CH.1.1.* "Orthrus" (17%) variants.

XBB.1.5.* "Kraken" (9%) is still significant, along with XBB.2.3.* "Acrux" (9%).

The variant mix in WA continues to be uniquely chaotic, reflecting its situation as a global crossroads. Even WA residents who've been racking up regular reinfections are likely to meet new variants capable of overcoming their immunity. Four variants are at 17%+ frequency, with another two around 10%.

The sample volumes seem representative up to May 16.

#COVID19 #Australia #WA #Perth #XBC #Deltacron #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus #CH_1_1 #Orthrus @auscovid19
🧵

Here's the latest variant picture for Western Australia.

The XBC.* Deltacron variant clan (31%) appears to have surged to dominance, although recent samples are a bit patchy.

You could throw a blanket over XBB.1.16.* "Arcturus" (20%), XBB.1.9.* "Hyperion" (19%) and CH.1.1.* "Orthrus" (17%) variants.

XBB.1.5.* "Kraken" (9%) is still significant, along with XBB.2.3.* "Acrux" (9%).

The variant mix in WA continues to be uniquely chaotic, reflecting its situation as a global crossroads. Even WA residents who've been racking up regular reinfections are likely to meet new variants capable of overcoming their immunity. Four variants are at 17%+ frequency, with another two around 10%.

The sample volumes seem representative up to May 16.

#COVID19 #Australia #WA #Perth #XBC #Deltacron #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus #CH_1_1 #Orthrus @auscovid19
🧵

Here's the latest variant picture for Western Australia.

The XBC.* Deltacron variant clan (31%) appears to have surged to dominance, although recent samples are a bit patchy.

You could throw a blanket over XBB.1.16.* "Arcturus" (20%), XBB.1.9.* "Hyperion" (19%) and CH.1.1.* "Orthrus" (17%) variants.

XBB.1.5.* "Kraken" (9%) is still significant, along with XBB.2.3.* "Acrux" (9%).

The variant mix in WA continues to be uniquely chaotic, reflecting its situation as a global crossroads. Even WA residents who've been racking up regular reinfections are likely to meet new variants capable of overcoming their immunity. Four variants are at 17%+ frequency, with another two around 10%.

The sample volumes seem representative up to May 16.

#COVID19 #Australia #WA #Perth #XBC #Deltacron #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus #CH_1_1 #Orthrus @auscovid19
🧵

Here's the latest variant picture for Western Australia.

The XBC.* Deltacron variant clan (31%) appears to have surged to dominance, although recent samples are a bit patchy.

You could throw a blanket over XBB.1.16.* "Arcturus" (20%), XBB.1.9.* "Hyperion" (19%) and CH.1.1.* "Orthrus" (17%) variants.

XBB.1.5.* "Kraken" (9%) is still significant, along with XBB.2.3.* "Acrux" (9%).

The variant mix in WA continues to be uniquely chaotic, reflecting its situation as a global crossroads. Even WA residents who've been racking up regular reinfections are likely to meet new variants capable of overcoming their immunity. Four variants are at 17%+ frequency, with another two around 10%.

The sample volumes seem representative up to May 16.

#COVID19 #Australia #WA #Perth #XBC #Deltacron #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus #CH_1_1 #Orthrus @auscovid19
🧵

Here's the latest variant picture for Western Australia.

The XBC.* Deltacron variant clan (31%) appears to have surged to dominance, although recent samples are a bit patchy.

You could throw a blanket over XBB.1.16.* "Arcturus" (20%), XBB.1.9.* "Hyperion" (19%) and CH.1.1.* "Orthrus" (17%) variants.

XBB.1.5.* "Kraken" (9%) is still significant, along with XBB.2.3.* "Acrux" (9%).

The variant mix in WA continues to be uniquely chaotic, reflecting its situation as a global crossroads. Even WA residents who've been racking up regular reinfections are likely to meet new variants capable of overcoming their immunity. Four variants are at 17%+ frequency, with another two around 10%.

The sample volumes seem representative up to May 16.

#COVID19 #Australia #WA #Perth #XBC #Deltacron #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus #CH_1_1 #Orthrus @auscovid19
🧵

Here's the latest variant picture for Switzerland.

XBB.1.5.* "Kraken" (42%) and XBB.1.9.* "Hyperion" (37%) have been dueling for dominance.

XBB.1.16.* "Arcturus" (23%) is rising sharply, and will be the next to challenge.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 5.

#COVID19 #Switzerland #XBB_1_16 #Arcturus #XBB_1_5 #Kraken #XBB_1_9 #Hyperion

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for the United Kingdom.

XBB.1.5.* "Kraken" (40%) has been declining steadily.

The challenge from XBB.1.9.* "Hyperion" (24%) appears to be fading.

XBB.1.16.* "Arcturus" (22%) has been growing steadily.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem somewhat representative up to May 18, although the volume appears to be declining, unfortunately.

#COVID19 #UK #XBB_1_5 #Kraken #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus
🧵

Here's the latest variant picture for South Korea.

XBB.1.9.* "Hyperion" (50%) has continued to dominate, with XBB.1.5.* "Kraken" (22%) slowly declining.

XBB.1.16.* "Arcturus" (14%) is rising, and might be the next to challenge.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 14.

#COVID19 #SouthKorea #XBB_1_9 #Hyperion

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Japan.

XBB.1.16.* "Arcturus" (30%) seems to have taken over dominance from XBB.1.9.* "Hyperion" (25%).

XBB.1.5.* "Kraken" (20%) is still significant.

XBB.2.3.* "Acrux" (7%) is rising, and might be the next to challenge.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 8.

#COVID19 #Japan #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Malaysia.

XBB.1.16.* "Arcturus" (39%) now looks dominant over XBB.1.9.* "Hyperion" (22%).

XBB.2.3.* "Acrux" (11%) is rising, and might be the next to challenge.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 18, but look a bit patchy.

#COVID19 #Malaysia #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_2_3 #Acrux

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Thailand.

XBB.1.16.* "Arcturus" (47%) is now dominant over XBB.1.9.* "Hyperion" (26%) and XBB.1.5.* "Kraken" (19%).

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 16.

#COVID19 #Thailand #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Queensland, Australia.

XBB.1.16.* "Arcturus" (32%) has surged to dominance.

The XBB.1.9.* "Hyperion" (24%) and XBB.1.5.* "Kraken" (19%) variants are still significant.

The "Deltacron" XBC.* variant (11%) and CH.1.1.* "Orthrus" (14%) are still in the frame.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 3. There are almost no sequences shared since that date - hopefully only a temporary bottleneck.

#COVID19 #QLD #Brisbane #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for New South Wales.

XBB.1.16.* "Arcturus" (29%) continues to battle XBB.1.9.* "Hyperion" (28%) for dominance.

XBB.1.5.* "Kraken" (18%) has been declining steadily, but is still significant.

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem somewhat representative up to May 25, although the volume appears to be declining, unfortunately.

#COVID19 #NSW #Sydney #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus #XBB_1_5 #Kraken @auscovid19
🧵

Here's the latest variant picture for the United States.

The sequencing volume is ~5X lower, after the ending of the public health emergency, so the picture is less clear.

The XBB.1.5.* "Kraken" clan (53%) is still dominant.

The leading challengers are XBB.1.9.* "Hyperion" (20%) and XBB.1.16.* "Arcturus" (14%). Be alert for conjunctivitis symptoms, which seem more common with the "Arcturus" variant.

The rise of new variants to significant levels implies increased reinfection risks, for those relying on immunity from a prior infection.

#COVID19 #USA #XBB_1_5 #Kraken #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus

Here's the latest variant picture for New South Wales.

XBB.1.16.* "Arcturus" (28%) has closed the gap with XBB.1.9.* "Hyperion" (30%) as they battle for dominance.

XBB.1.5.* "Kraken" (20%) has been declining steadily, but is still significant.

The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem somewhat representative up to May 16, although the volume appears to be declining, unfortunately.

#COVID19 #NSW #Sydney #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus #XBB_1_5 #Kraken @auscovid19
🧵

Here's the latest variant picture for Western Australia.

The XBB.1.9.* "Hyperion" clan (31%) is battling with XBB.1.5.* "Kraken" variant (23%) for dominance.

XBB.1.16.* "Arcturus" (20%) is growing quite rapidly. Be alert for conjunctivitis symptoms, which seem more common with that variant.

The variant mix in WA continues to be uniquely chaotic, reflecting it's situation as a global crossroads. Even WA residents who've been racking up regular reinfections are likely to meet globally obscure variants capable of overcoming their immunity.

The sample volumes seem representative up to May 12.

#COVID19 #Australia #WA #Perth #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus @auscovid19

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for China.

XBB.1.9.* "Hyperion" (45%) is still dominant dominant.

XBB.1.16.* "Arcturus" (25%) looks like challenging next.

New clans XBB.1.22.* "Bellatrix" (9%) and XBB.2.3.* "Acrux" (8%) are beginning to rise.

The vigorous mix of very different variants raises the re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 10.

#COVID19 #China #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus #XBB_1_22 #Bellatrix #XBB_2_3 #Acrux

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Taiwan.

Sharing of sample data seemed to stop for a couple of months, but recently resumed.

XBB.1.16.* "Arcturus" (30%) seemed to recently take over dominance from XBB.1.9.* "Hyperion" (23%) XBB.1.5.* "Kraken" (14%).

Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 12.

#COVID19 #Taiwan #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for the Netherlands.

XBB.1.5.* "Kraken" (48%) is still dominant for now over XBB.1.9.* "Hyperion" (22%).

There are some early signs of growth from XBB.1.16.* "Arcturus" (8%) and XBB.2.3.* "Acrux" (6%).

The sample volumes seem representative up to May 7.

#COVID19 #Netherlands #XBB_1_5 #Kraken #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Thailand.

XBB.1.16.* "Arcturus" (27%) is scrapping for dominance with XBB.1.5.* "Kraken" (21%) and XBB.1.9.* "Hyperion" (19%).

Be alert for conjunctivitis symptoms, particularly associated with Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 2.

#COVID19 #Thailand #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for Malaysia.

Sequencing volumes collapsed in mid-April and have remained sparse and patchy since, so these results are low-confidence.

XBB.1.16.* "Arcturus" (42%) may have overhauled XBB.1.9.* "Hyperion" (33%).

Be alert for conjunctivitis symptoms, particularly associated with Arcturus variant.

The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

XBB.* "Gryphon" (11%) has been unusually significant. The most common sub-lineage from that clan has been XBB.1.24, featuring a Spike F486P mutation.

The sample volumes seem representative up to April 17.

#COVID19 #Malaysia #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion

Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme

Here's the latest variant picture for New South Wales.

XBB.1.9.* "Hyperion" (35%) is now battling XBB.1.16.* "Arcturus" (22%) for dominance.

XBB.1.5.* "Kraken" (18%) has been declining steadily, but is still significant.

The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.

The sample volumes seem representative up to May 9.

#COVID19 #NSW #Sydney #XBB_1_9 #Hyperion #XBB_1_5 #Kraken @auscovid19
🧵